ResearcherUniversity at Buffalo, State University of New YorkNo recent work listed
Xu Zhu
Matched on ORCID iD 0000-0001-9300-4307; OpenAlex author ID A5101468224. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers
Papers 3
- Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts. Co-author DOI 10.1007/s10928-018-9603-z↗
- Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells. Co-author DOI 10.3389/fphar.2018.00084↗
- Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells. Co-author DOI 10.1007/s10928-015-9429-x↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert M. Straubinger · 3 shared papers, 2015–2018 · strength 0.31
- Paper Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xe… DOI 10.1007/s10928-018-9603-z↗
- Paper Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells. DOI 10.3389/fphar.2018.00084↗
- Paper Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells. DOI 10.1007/s10928-015-9429-x↗
- William J. Jusko · 3 shared papers, 2015–2018 · strength 0.31
- Paper Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xe… DOI 10.1007/s10928-018-9603-z↗
- Paper Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells. DOI 10.3389/fphar.2018.00084↗
- Paper Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells. DOI 10.1007/s10928-015-9429-x↗
- Jun Qu · 1 shared paper, 2018 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.